| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 33,305 | 36,325 | 33,787 | 32,805 | | Cost of Revenue | (9,921) | 18,878 | 18,089 | 26,634 | | | Gross Profit | 43,226 | 17,447 | 15,698 | 6,171 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 39,318 | 12,157 | 11,850 | 4,151 | | Non Recurring | 440 | (427) | 106 | 3,502 | | Others | 1,253 | 1,269 | 1,312 | 1,396 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,202 | 4,448 | 2,430 | (2,878) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (20) | (434) | 44 | 78 | | Earnings Before Interest And Taxes | 2,195 | 4,014 | 2,474 | (2,800) | | Interest Expense | 277 | 426 | 474 | 499 | | Income Before Tax | 1,918 | 3,588 | 2,000 | (3,299) | | Income Tax Expense | 679 | 1,220 | 680 | (1,344) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 750 | 2,368 | 1,320 | (1,955) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,239 | 2,368 | 1,320 | (1,955) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,239 | $2,368 | $1,320 | ($1,955) |
|
0.51% Nasdaq 
0.06 (1.01%) 
Income Statement
